Coronary Stent Market Report: Trends, Forecast and Competitive Analysis to 2030

Coronary Stent Trends and Forecast

The future of the global coronary stent market looks promising with opportunities in the hospital, cardiac center, and ambulatory surgical center markets. The global coronary stent market is expected to reach an estimated $11.4 billion by 2030 with a CAGR of 5.4% from 2024 to 2030. The major drivers for this market are rising prevalence of coronary artery disease, escalating demand for minimally invasive procedures, and emergence of bioresorbable vascular scaffolds.

• Lucintel forecasts that, within the product category, drug-eluting stent is expected to witness the highest growth over the forecast period.

• Within the end use category, hospital is expected to witness the higher growth over the forecast period.

• In terms of regions, North America is expected to witness highest growth over the forecast period. Gain valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Coronary Stent Market

The coronary stent market is well into an era of transformative change underpinned by technological, material science, and clinical practice advancements. The growing demand for minimally invasive procedures and healthcare provider interest in better patient outcomes fuel innovative trends in this arena. These changing trends are oriented toward improved effectiveness, safety, and patient comfort.

• Bioabsorbable Stents: These are a class of biodegradable or bioabsorbable stents that dissolve in the body over time, thereby eliminating the long-term implantation of metals. This emergent trend addresses concerns about chronic inflammation and restenosis linked to permanent stents. Over time, bioabsorbable stents gradually disappear, reducing the risk of late stent thrombosis, and offer improved vessel healing.

• DES Innovations: New generations of drug-eluting stents (DES) are in development, featuring advanced drug coatings that can elute medications more effectively to counteract restenosis. Enhanced drug formulation and coating technologies further improve stent performance, providing superior long-term outcomes. These innovations contribute to a reduction in vessel narrowing and minimize the need for re-interventions.

• Personalized Stent Therapy: The concepts of personalized medicine are having a significant impact on the design and delivery of stents. Tailoring stent selection and treatment methodologies based on the patient’s characteristics, such as genetic profiling and lesion type, enables more effective and definitive interventions. The goal is to optimize treatment outcomes and reduce complications according to individual patient factors.

• Advanced Imaging Techniques: The integration of advanced imaging modalities such as intravascular ultrasound (IVUS) and optical coherence tomography (OCT) will continue to enhance the precision of stent deployment and post-procedure assessment. These technologies provide detailed insights into vessel anatomy and stent apposition, improving decision-making during procedures and enhancing patient outcomes.

• Minimally Invasive Technologies: Smaller, more flexible stents and their delivery systems significantly enhance the minimally invasive nature of coronary interventions. These technologies aim to reduce procedural complications, shorten recovery times, and improve patient comfort. Innovations in catheter design and stent delivery methods contribute to safer and more efficient procedures. These emerging trends are collectively driving the evolution of the coronary stent market through improvements in stent technology, personalized treatment approaches, and the use of advanced imaging modalities. As innovation in the industry progresses, it is expected that patients will experience better safety, efficacy, and overall outcomes following coronary interventions.

Recent Developments in the Coronary Stent Market

Recent advances in the coronary stent market focus on improving patient outcomes and increasing stent functionality while reducing the drawbacks of existing technologies. These developments have been made possible due to rapidly advancing technology and increased research efforts. The following are five recent developments:

• New Designs for Drug-Eluting Stents: Recently, next-generation drug-eluting stents have been introduced, featuring new drug coatings and polymer technologies. These stents are designed to release drugs more effectively over longer periods, reducing restenosis rates and ultimately improving long-term vessel patency. The new designs ensure better outcomes for patients and lower rates of repeat procedures.

• Improved Stent Materials: New materials, including bioresorbable polymers and novel metal alloys, are being used to create more resistant and elastic stents. These materials enhance performance by minimizing complications while ensuring good integration with the arterial wall. Advanced materials also help address problems related to stent fractures and late thrombosis.

• Improved Delivery Systems: More precise and user-friendly stent delivery systems are being developed to improve procedural efficiency. Innovations in catheter design, including smaller profiles and advanced navigation features, facilitate easier stent deployment by clinicians in a safe and accurate manner. These improvements reduce procedural time and lower the risk of complications.

• Artificial Intelligence Integration: Artificial intelligence (AI) is being integrated into stent deployment systems to aid in real-time decision-making and enhance procedural outcomes. AI algorithms analyze imaging data to assist in sizing, placement, and optimization of the stent for more personalized and effective treatments. This marks a significant step toward precision medicine in cardiology.

• Patient-Centric Designs: There is a growing focus on designing stents that address patient-specific needs, such as reducing the occurrence of restenosis and late complications. Recent developments prioritize biocompatibility and other patient-centric factors, aiming to enhance the quality of life and overall treatment satisfaction. These developments represent significant advances in the coronary stent market, with ongoing improvements in stent design, materials, and delivery systems. Advanced technologies and patient-oriented approaches will ensure a future for coronary interventions that is not only more effective and safer but also tailored to each patient's needs.

Strategic Growth Opportunities for Coronary Stent Market

Strategic growth opportunities continue to emerge in the coronary stent market. These opportunities are driven by technological advancements, the increasing prevalence of cardiovascular diseases, and changes in healthcare needs. Identifying and utilizing these emerging opportunities will be critical for driving growth and innovation for market stakeholders.

• Growth Opportunity from the Expansion of Emerging Markets: Increasing access to coronary stents in emerging markets, where cardiovascular diseases are on the rise, presents significant opportunities. The local production of low-priced stent options is improving market penetration and increasing access to healthcare services in these regions.

• Growth Potential in Drug-Eluting Stents: There is immense growth potential in developing next-generation drug-eluting stents with improved drug delivery systems and coatings. These stents offer advanced performance with lower restenosis rates and improved patient outcomes.

• Bioresorbable Stents: The use of bioresorbable stents is another key growth opportunity. These stents dissolve after providing the necessary support to the vessel, addressing long-term complications associated with permanent stents.

• Integration of Digital Health Technologies: The introduction of digital health technologies, such as advanced imaging and data analytics, into stenting procedures may offer new avenues for improving procedural outcomes and enhancing patient management. Improved precision, combined with real-time data, can lead to better stent deployment and overall treatment success.

• Personalized Medicine Approaches: The development of stents tailored to specific patient needs, including customized designs for varying vessel sizes and disease conditions, presents additional growth opportunities. Personalized medicine approaches improve the efficacy and safety of treatments, meeting the diverse needs of patient populations. Other strategic growth opportunities within the coronary stent market include expansion into emerging markets, advanced DES development, bioresorbable stents, digital health integration, and personalized medicine approaches. These opportunities are driving innovation and market growth, leading to improvements in patient treatment, accessibility, and outcomes, and shaping the future of the coronary stent industry.

Coronary Stent Market Driver and Challenges

Drivers and challenges influencing the coronary stent market include technological development, economic access, and regulatory approvals. These factors impact growth, innovation, and technology adoption. While technological advances and increasing healthcare investments drive the market, economic constraints and regulatory obstacles can be overwhelming. Successfully navigating the dynamic landscape of the coronary stent market and realizing value from emerging opportunities depends on understanding these drivers and challenges. The factors responsible for driving the coronary stent market are:

• Technological Advancements: Innovations in coronary stent technology, such as the development of bioresorbable stents and new generations of drug-eluting stents, are significant drivers for the market. These advancements improve stent performance, reduce complications like restenosis and thrombosis, and ensure better patient outcomes. Bioresorbable materials, which dissolve over time, present a promising option compared to traditional metallic stents, reducing chronic health risks.

• Increasing Demand for Coronary Interventions: The rising prevalence of cardiovascular diseases, particularly due to aging populations and lifestyle-related risk factors, is a key driver for the market. This increasing demand for effective coronary interventions has spurred continuous innovation in stent design and functionality.

• Regulatory Support and Innovation Incentives: Favorable regulatory frameworks and incentives for medical device innovation are bolstering the growth of the coronary stent market. Supportive regulations that streamline approval processes and provide grants or subsidies for research and development encourage the introduction of advanced stent technologies. Challenges in the coronary stent market are:

• High-Cost Advanced Technologies: The high costs of newer advanced coronary stent technologies, such as bioresorbable and next-generation DES, pose significant challenges in accessing these technologies, particularly in cost-sensitive markets. These high costs affect affordability and access to coronary stent treatments.

• Regulatory Challenges: Navigating complex regulatory requirements and reimbursement issues for new stent technologies is a major challenge. The lengthy and costly approval process, combined with variable reimbursement policies across regions, may delay market entry and reduce the potential adoption of innovative stent solutions.

• Complications and Device Failures: Despite technological advances, coronary stents still carry risks of complications, including restenosis, thrombosis, and device failures. These complications can negatively impact patient outcomes and safety, presenting challenges to market growth. Ongoing research and improvements in stent design are needed to improve device reliability and increase patient confidence. The growth drivers for the coronary stent market include technological advancements, the increasing prevalence of cardiovascular diseases, regulatory support, growing healthcare expenditure, and a shift toward minimally invasive procedures. However, high costs, complex regulatory environments, and complication risks need to be addressed to fully realize market opportunities. Identifying these factors and trends will drive further technological advancements in coronary stents, improving patient outcomes and supporting continued market growth.

List of Coronary Stent Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies coronary stent companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the coronary stent companies profiled in this report include-

• Abbott Laboratories

• B. Braun Melsungen

• BIOTRONIK

• Boston

• Cook Medical

Coronary Stent by Segment

The study includes a forecast for the global coronary stent by product, material, end use, and region.

Coronary Stent Market by Product [Analysis by Value from 2018 to 2030]:

• Drug-Eluting Stent

• Bare-Metal Coronary Stent

• Bioabsorbable Stent

Coronary Stent Market by Material [Analysis by Value from 2018 to 2030]:

• Metallic Stents

• Cobalt Chromium

• Platinum Chromium

• Nickel Titanium

• Stainless Steel

• Others

Coronary Stent Market by End Use [Analysis by Value from 2018 to 2030]:

• Hospitals

• Cardiac Centers

• Ambulatory Surgical Centers

• Others

Coronary Stent Market by Region [Analysis by Value from 2018 to 2030]:

• North America

• Europe

• Asia Pacific

• The Rest of the World

Country Wise Outlook for the Coronary Stent Market

The coronary stent market is experiencing significant development across major global economies. Changes in stent technology, modifications in regulatory frameworks, and evolving healthcare needs are shaping market dynamics. Recent developments reflect improvements in stent design and functionality, driven by new technology and demographic trends.

• United States: In the U.S., bioresorbable stents and newer DES are gaining traction. These developments aim to overcome the long-term complications of traditional metallic stents. Next-generation DES, with improved safety profiles and a lower risk of restenosis, are seeing increased adoption. Advanced imaging techniques integrated into stent placement procedures are enhancing procedural precision and improving patient outcomes.

• China: The coronary stent market in China is growing rapidly, with a focus on affordability and accessibility. The expansion of local manufacturing capabilities and the availability of cost-effective stent options are improving market penetration. Chinese companies are also advancing stent technology through innovations in design and materials, improving performance and reducing complications. Government support for medical device innovation is accelerating the growth of the market.

• Germany: Germany is a leading adopter of the latest stent technologies, including bioresorbable stents and advanced drug coatings. The country is also integrating digital health concepts into stent-related procedures, including advanced imaging and data analytics, which enhance patient outcomes and procedural efficiency. Germany's strict regulatory environment ensures that only high-quality stents are approved, contributing to high standards in coronary interventions.

• India: The coronary stent market in India is booming due to rising cardiovascular diseases and advancements in stent technologies. Recent developments include affordable varieties of stents and improvements in drug-eluting stent designs. Indian companies are investing in research and development to produce innovative solutions for improved access and treatment efficiency.

• Japan: Japan is known for its technological innovations and a strong emphasis on patient-specific solutions. Recent developments include the design of high-performance stents with increased biocompatibility and advanced drug delivery mechanisms. New materials and design approaches are further improving stent functionality and patient safety. The country’s robust healthcare infrastructure supports the rapid adoption of advanced stent technologies and continuous improvements in coronary intervention practices.

Features of the Global Coronary Stent Market

Market Size Estimates: Coronary stent market size estimation in terms of value ($B). Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions. Segmentation Analysis: Coronary stent market size by product, material, end use, and region in terms of value ($B). Regional Analysis: Coronary stent market breakdown by North America, Europe, Asia Pacific, and Rest of the World. Growth Opportunities: Analysis of growth opportunities in different products, materials, end uses, and regions for the coronary stent market. Strategic Analysis: This includes M&A, new product development, and competitive landscape of the coronary stent market. Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
If you are looking to expand your business in this market or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

FAQ

Q1. What is the coronary stent market size? Answer: The global coronary stent market is expected to reach an estimated $11.4 billion by 2030. Q2. What is the growth forecast for coronary stent market? Answer: The global coronary stent market is expected to grow with a CAGR of 5.4% from 2024 to 2030. Q3. What are the major drivers influencing the growth of the coronary stent market? Answer: The major drivers for this market are rising prevalence of coronary artery disease, escalating demand for minimally invasive procedures, and emergence of bioresorbable vascular scaffolds. Q4. What are the major segments for coronary stent market? Answer: The future of the coronary stent market looks promising with opportunities in the hospital, cardiac center, and ambulatory surgical center markets. Q5. Who are the key coronary stent market companies? Answer: Some of the key coronary stent companies are as follows:

• Abbott Laboratories

• B. Braun Melsungen

• BIOTRONIK

• Boston

• Cook Medical Q6. Which coronary stent market segment will be the largest in future? Answer: Lucintel forecasts that drug-eluting stent is expected to witness the highest growth over the forecast period. Q7. In coronary stent market, which region is expected to be the largest in next 5 years? Answer: North America is expected to witness highest growth over the forecast period. Q.8 Do we receive customization in this report? Answer: Yes, Lucintel provides 10% customization without any additional cost.